No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap

From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...

Genes from Neanderthals can affect the correct drug dosage

A fifth of all Europeans carry gene variants inherited from Neanderthals, which cause certain drugs to break down more slowly. This may have implications for th...

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Lundbeck behind the first EU-approved intravenous migraine treatment

A preventive, intravenous treatment for migraines has been approved in the EU for the first time.

A new giant among our microscopes

Two technologies in one machine.

“Together Stockholm-Uppsala and Medicon Valley can make Scandinavia a leading life science region”

“Denmark, Sweden, Norway and Finland all have national life science strategies, but the Swedish strategy is the only one explicitly emphasizing the Nordic dimen...

The first vaccine derived from cowpox

The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...

Novo Nordisk to invest billions in Danish manufacturing facilities

Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...

Guard Therapeutics: ”Mötet med FDA är en tydlig validering av våra kliniska fas II-data”

Det svenska bioteknikföretaget Guard Therapeutics meddelar att de fått positiv återkoppling från den amerikanska läkemedelsmyndigheten, FDA, efter ett möte gäll...

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Behöver du vätskekylning under noll grader?

SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!

Ossiform: Quality control of 3D printed bone implants

Ossiform chose the GOM Scan 1.

Nya life science-navet – "Väldigt positivt för regionen"

Beskedet i förra veckan om att en vaccin- och läkemedelsfabrik utanför Sundsvall ska bli Sveriges nya innovationshubb för avancerade läkemedel fick förmodligen ...

Drug development creates new challenges for regulators

This is how Anette Steenberg will put Medicon Valley on the world map

Anette Steenberg has been CEO of the Swedish-Danish life science cluster Medicon Valley Alliance since 1 November last year. Life Science Sweden called her to a...

Mendus får snabbspår i USA för blodcancerbehandling

Immunterapibolaget Mendus har beviljats ett snabbspår, så kallat Fast Track Designation, i USA för sin ledande läkemedelskandidat vididencel för behandling av a...

Google satsar på life science

Med en miljard dollar i potten söker It-jättens riskkapitalfond innovativa biotech-lösningar att investera i.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Google Health läggs ned

Hälsosatsning med elektroniskt journalsystem vann inte folkets hjärta. Nu stänger Google ner den tre år gamla sajten.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Sofia Wallström is Lif's new CEO

Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...